Figure 1From: The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical studyPlasma glucose response in meal tolerance test. Plasma glucose level at 60, 120, and 180 min was significantly improved by mitiglinide (a). Whereas, glimepiride showed a significant improve plasma glucose at only 180 min (b).Back to article page